BlackRock rallies post-earnings as the Street turns bullish
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
BLK is having its best week in months, and the catalyst is clear: a strong Q3 print followed by a wave of analyst upgrades that has redrawn the consensus picture almost overnight.
The stock closed at $1,128.68 on October 20, up 5.9% on the week. That is a sharp reversal from the pattern noted in prior notes, where BLK had a habit of selling off after results. The October 14 Q3 print bucked that trend with a 5.1% one-day gain. The stock is now up 5.5% over the past month, and the tone from the Street has shifted to match.
The analyst reaction to Q3 has been decisive. TD Cowen's Bill Katz upgraded the stock to Buy from Hold on October 20, lifting his target to $1,405 from $1,212, the freshest and most significant move of the week. Before that, Morgan Stanley maintained Overweight and raised to $1,531 from $1,468 on October 15, reversing the direction of two prior trims from that desk. JPMorgan kept Overweight and nudged its target to $1,449. UBS and KBW both lifted targets while holding positive ratings. Barclays was the lone dissenter on the day, trimming its target modestly to $1,410 from $1,420 while staying Overweight. The consensus now stands at 12 buys and one hold, with a mean target of $1,351, implying about 20% upside from current levels. Analyst recommendation divergence ranks in the 89th percentile of the ORTEX universe, near the top of the range.
The bull case centres on AUM scale and fee growth momentum. The firm reported 6% organic base fee growth last quarter, ahead of its own 5%-plus target for 2030, with $13.464 trillion in assets under management. The bear case is margin pressure: G&A expenses are projected to grow 13.3% in 2025, and operating margin estimates have been revised down to 43.9% for 2025. The PE multiple has expanded to 17.7 times over the past month, and the price-to-book sits at 2.9 times. EPS momentum is firm, ranking in the 84th percentile on a 30-day basis and 66th on a 90-day basis, while EPS surprise ranks more modestly at the 42nd percentile.
Short positioning and the lending market contribute nothing to the debate this week, consistent with what prior notes have reported. Short interest holds at 1.3% of the float, roughly 2 million shares. Borrow availability remains effectively unlimited, and the cost to borrow, while up 35% over the week in percentage-change terms, is still just 0.41%, a trivial absolute level for a stock of this size and liquidity. Options positioning has drifted to its most call-heavy level of the recent period. The put/call ratio has fallen to 0.69, just below the 20-day average of 0.72 and close to the 52-week low of 0.68. That is a mildly bullish lean from options traders, not an extreme reading, but it points in the same direction as the analyst upgrades rather than against them.
Peers moved in the same direction but not by as much. KKR gained 2.4% on the week and ARES added 0.6%, while BAM was roughly flat. BLK's outperformance this week is its own story, driven by the earnings reaction and analyst re-rating rather than a sector-wide move.
Wikipedia attention for BLK has picked up, with a z-score of 1.9 against its own 90-day history as of October 13. That signals elevated retail attention, likely a consequence of the earnings print and upgrade wave. It is a colour point, not a leading indicator.
The next earnings event is scheduled for January 15, 2027, giving the Street 86 days to assess whether the Q3 momentum in organic fee growth holds and whether margin pressures ease or deepen further.
Stocks in this article
See the live data behind this article on ORTEX.
Open BLK on ORTEX →How this article was generated
- Generated
- 21 Oct 2026, 21:04
- Data as of
- 21 Oct 2026, 21:03
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.